Guglielmina Froldi

Prof. Guglielmina Froldi

University of Padova - Department of Pharmaceutical and Pharmacological Sciences
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Food Chemistry
Verified
Journal Article
Closed access
ZCZheng Chen
Zheng Chen
RBRiccardo Bertin
Riccardo Bertin
Guglielmina FroldiGuglielmina Froldi
Guglielmina Froldi

8 April 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Guglielmina FroldiGuglielmina Froldi
Guglielmina Froldi
Metformin is a synthetic biguanide used as an antidiabetic drug in type 2 diabetes mellitus, achieved by studying the bioactive metabolites of Galega officinalis L. It is also used off-label for various other diseases, such as subclinical diabetes, obesity, polycystic ovary syndrome, etc. In addition, metformin is proposed as an add-on therapy for several conditions, including autoimmune diseases, neurodegenerative diseases, and cancer. Although metformin has been used for many decades, it is still the subject of many pharmacodynamic and pharmacokinetic studies in light of its extensive use. Metformin acts at the mitochondrial level by inhibiting the respiratory chain, thus increasing the AMP/ATP ratio and, subsequently, activating the AMP-activated protein kinase. However, several other mechanisms have been proposed, including binding to presenilin enhancer 2, increasing GLP1 release, and modification of microRNA expression. Regarding its pharmacokinetics, after oral administration, metformin is absorbed, distributed, and eliminated, mainly through the renal route, using transporters for cationic solutes, since it exists as an ionic molecule at physiological pH. In this review, particular consideration has been paid to literature data from the last 10 years, deepening the study of clinical trials inherent to new uses of metformin, the differences in effectiveness and safety observed between the sexes, and the unwanted side effects. For this last objective, metformin safety was also evaluated using both VigiBase and EudraVigilance, respectively, the WHO and European databases of the reported adverse drug reactions, to assess the extent of metformin side effects in real-life use.

1 February 2011 in Current Cancer Drug Targets
Verified
Journal Article
Closed access
PDF file
MMMonica Montopoli
Monica Montopoli
MBM. Bellanda
M. Bellanda
FLF. Lonardoni
F. Lonardoni
EREugenio Ragazzi
Eugenio Ragazzi
PDP. Dorigo
P. Dorigo
LCL. Caparrotta
L. Caparrotta
The way cancer cells escape cisplatin-induced apoptosis has not been completely elucidated yet. We questioned the relevance of “metabolic reprogramming” in cisplatin-resistance by studying mitochondrial function and metabolism in human ovarian carcinoma cell lines, cisplatin-sensitive (2008) and -resistant (C13). C13 cells, in comparison to 2008 cells, showed lower apoptotic response to cisplatin exposure, lower basal oxygen consumption (4.2±0.2 vs 6.5±0.7 fmol/cell/min, p < 0.005) and a lower basal transmembrane mitochondrial potential (ΔΨm) (18.7±1.5 vs 32.2±1 MFI p < 0.001). Moreover, C13 cells showed a lower sensitivity to rotenone and oligomycin, two mitochondrial respiratory chain inhibitors. To further investigate the impact of mitochondria on cisplatin-resistance, 2008 and C13 cells were depleted of their mitochondrial DNA (rho0-clones). The cytotoxicity of cisplatin was lower in 2008-rho0clones than in 2008 cells (IC50 of 3.56 μM and 0.72 μM, respectively) but similar between C13-rho0 and C13 cells (IC50 of 5.49 μM and 6.49 μM, respectively). The time-course of cell viability in glucose-free galactose medium indicated that C13 cells are more strictly dependent on glucose than 2008 cells. 1H-NMR spectroscopy showed a higher basal content of intracellular glutathione (GSH) and mobile lipids (MLs) in C13 cells as compared to 2008 cells, with higher lipid accumulation mainly within cytoplasmic droplets of the C13 cells. These findings allow us to propose a “metabolic remodelling” of ovarian carcinoma cells to a lipogenic phenotype, which includes alteration of mitochondrial function, as an advantageous mechanism to escape cisplatin-induced apoptosis. This hypothesis is of interest to exploit new pharmacological targets to improve the clinical impact of platinum drugs.


1 November 2020 in Medical Hypotheses
Verified
Journal Article
Closed access
Guglielmina FroldiGuglielmina Froldi
Guglielmina Froldi
PDPaola Dorigo
Paola Dorigo

3 October 2014 in Natural Product Research
Verified
Journal Article
Closed access
MDMaddalena Donati
Maddalena Donati
AMAndrea Mondin
Andrea Mondin
ZCZheng Chen
Zheng Chen
FMFabricio Mendes Miranda
Fabricio Mendes Miranda
BNBaraquizio Braga Do Nascimento
Baraquizio Braga Do Nascimento
Guglielmina FroldiGuglielmina Froldi
Guglielmina Froldi
The essential oils (EOs) from the Brazilian species Croton zehntneri, Pterodon emarginatus and Schinopsis brasiliensis were examined for their chemical constituents, and antioxidant and antimicrobial activities. The composition of EOs was determined by using gas chromatography coupled with mass spectrometry analysis, while the antioxidant activity was evaluated through the 1,1-diphenyl-2-picrylhydrazyl (DPPH) and oxygen radical absorbance capacity (ORAC) assays. Furthermore, the antimicrobial activity was investigated against Escherichia coli and Pseudomonas aeruginosa (both Gram-negative), Staphylococcus aureus (Gram-positive) and Candida parapsilosis (fungus). The main components of C. zehntneri, P. emarginatus and S. brasiliensis were identified as estragole, trans-anethole, β-caryophyllene and myrcene. Among the EOs, P. emarginatus showed the highest antioxidant activity, with an IC50 of 7.36 mg/mL and a Trolox equivalent antioxidant capacity of 3748 μmol/g determined by DPPH and ORAC assays, respectively. All EOs showed low activities against the bacterial strains tested, whereas the C. zehntneri oil and its main constituent estragole exhibited an appreciable antifungal activity against C. parapsilosis.